Kenealy, M., Seymour, J., Benson, W., Stevenson, W., Eek, R., Zantomio, D., . . . Zannino, D. (2013). P-272 The combination of azacitidine and lenalidomide is deliverable without unexpected toxicity; interim safety results of the ALLG MDS4 randomised trial. Leukemia Research, 37, S145. https://doi.org/10.1016/S0145-2126(13)70319-9
Chicago Style (17th ed.) CitationKenealy, M., et al. "P-272 The Combination of Azacitidine and Lenalidomide Is Deliverable Without Unexpected Toxicity; Interim Safety Results of the ALLG MDS4 Randomised Trial." Leukemia Research 37 (2013): S145. https://doi.org/10.1016/S0145-2126(13)70319-9.
MLA (9th ed.) CitationKenealy, M., et al. "P-272 The Combination of Azacitidine and Lenalidomide Is Deliverable Without Unexpected Toxicity; Interim Safety Results of the ALLG MDS4 Randomised Trial." Leukemia Research, vol. 37, 2013, p. S145, https://doi.org/10.1016/S0145-2126(13)70319-9.